Cargando…
Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
CONTEXT: Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients receiving immunotherapy in the reporting of symptoms, may o...
Autores principales: | Tolstrup, Lærke K., Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B., Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515745/ https://www.ncbi.nlm.nih.gov/pubmed/30900035 http://dx.doi.org/10.1186/s41687-019-0111-8 |
Ejemplares similares
-
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences
por: Tolstrup, Lærke K, et al.
Publicado: (2020) -
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
por: Tolstrup, Lærke K., et al.
Publicado: (2020) -
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form
por: Tolstrup, Lærke K., et al.
Publicado: (2018) -
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
por: Tolstrup, Lærke K., et al.
Publicado: (2022) -
The cost of living with cancer during the second wave of COVID-19: A mixed methods study of Danish cancer patients' perspectives
por: Dieperink, Karin Brochstedt, et al.
Publicado: (2021)